News

Researchers at Washington University School of Medicine in St. Louis have upended decades-old dogma of how connections between brain cells are rearranged during states of heightened vigilance or attention. The team found that a brain chemical associated with alertness, attention and learning alters brain connectivity and function not by acting directly on neurons, the cells […]

A team of WashU Medicine researchers has discovered a promising new use for Prozac, which is the brand name of the antidepressant fluoxetine, in the treatment of children with rare forms of epilepsy. In a Frontiers of Pharmacology case report published earlier this year, the researchers describe how fluoxetine treatment of two siblings with developmental and epileptic encephalopathy […]

LaMont Reed’s path to WashU Medicine began with a simple desire to volunteer at BJC. During his interview, he expressed a heartfelt wish to understand what it meant to work in a hospital and make a difference in people’s lives. That conversation led to a position as a patient service representative in Radiation Oncology, launching […]

On April 24, 2025, the Office of Technology Management hosted the eighth annual Celebration of Inventors, an event to honor and recognize Washington University inventors, researchers and faculty entrepreneurs. Honorees included 2024 United States Patent and Trademark Office (USPTO) awardees; newly elected National Academy of Inventors Fellow and Senior Members; and the recipient of the 2025 […]

The Food and Drug Administration’s approval in 2023 of lecanemab — a novel Alzheimer’s therapy shown in clinical trials to modestly slow disease progression — was met with enthusiasm by many in the field as it represented the first medication of its kind able to influence the disease. But side effects — brain swelling and […]